Stocks›IONS›Earnings

Ionis Pharmaceuticals earnings

When IONS reports, and what its stock did after each report.

Next report

Expected around early February, going by its own filing history. The company has not announced a date yet. Its matching report came Feb 25, 2026 and Feb 19, 2025, before the open.

Who else reports that week: the earnings calendar.

Last report: Nov 9, 2026, 07:00 ET (before the open). The filing on SEC EDGAR ↗

After each report

SEC EDGAR · 1D EOD

Across the last 6 reports we hold closes for, the first close moved a median 3.27% either way. Up 2 of 6.

Moves are only shown for reports where we hold closing prices.

  1. Nov 9, 202607:00 ET · before the open8-K ↗−21.36%1DRevenue $242.7M+54.9% y/yEPS −$0.66quarter to Sep 30, 2026
  2. Jul 29, 202607:31 ET · before the open8-K ↗−2.28%1DRevenue $267.9M−40.7% y/yEPS −$0.69quarter to Jun 30, 2026
  3. Apr 29, 202607:00 ET · before the open8-K ↗+4.25%1DRevenue $246.1M+87.0% y/yEPS −$0.56quarter to Mar 31, 2026
  4. Feb 25, 202607:00 ET · before the open8-K ↗−5.29%1DRevenue $203.3M−10.3% y/yEPS −$1.41quarter to Dec 31, 2025
  5. Jan 12, 202607:00 ET · before the open8-K ↗+1.69%1DRevenue $203.3M−10.3% y/yEPS −$1.41quarter to Dec 31, 2025
  6. Oct 29, 202507:06 ET · before the open8-K ↗−2.30%1DRevenue $156.7M+17.1% y/yEPS −$0.80quarter to Sep 30, 2025
  7. Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
  8. Jul 30, 202511:16 ET · during the session8-K ↗Revenue $452.0M+100.7% y/yEPS $0.70quarter to Jun 30, 2025
  9. Apr 30, 202511:15 ET · during the session8-K ↗Revenue $131.6M+10.1% y/yEPS −$0.93quarter to Mar 31, 2025
  10. Feb 19, 202511:15 ET · during the session8-K ↗Revenue $226.6M−30.2% y/yEPS −$0.66quarter to Dec 31, 2024
  11. Nov 6, 202411:15 ET · during the session8-K ↗Revenue $133.8M−7.2% y/yEPS −$0.95quarter to Sep 30, 2024
  12. Aug 1, 202411:15 ET · during the session8-K ↗Revenue $225.3M+19.6% y/yEPS −$0.45quarter to Jun 30, 2024
  13. May 7, 202411:15 ET · during the session8-K ↗Revenue $119.5M−8.4% y/yEPS −$0.98quarter to Mar 31, 2024
  14. Feb 21, 202411:17 ET · during the session8-K ↗Revenue $324.5M+113.6% y/yEPS −$0.06quarter to Dec 31, 2023
  15. Nov 2, 202311:15 ET · during the session8-K ↗Revenue $144.2M−9.7% y/yEPS −$1.03quarter to Sep 30, 2023
  16. Aug 9, 202311:15 ET · during the session8-K ↗Revenue $188.4M+40.8% y/yEPS −$0.60quarter to Jun 30, 2023
  17. May 3, 202311:15 ET · during the session8-K ↗Revenue $130.5M−8.0% y/yEPS −$0.87quarter to Mar 31, 2023

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. Prior-session closes only; not a forecast, not advice.

IONS: stories, the record and filings →